Literature DB >> 12649048

Cost-effectiveness of primary prevention of coronary heart disease through risk factor intervention in 60-year-old men from the county of Stockholm--a stochastic model of exercise and dietary advice.

Peter Lindgren1, Per Fahlstadius, Mai-Lis Hellenius, Bengt Jönsson, Ulf de Faire.   

Abstract

BACKGROUND: Recent screenings show a high prevalence of cardiovascular risk factors in the county of Stockholm. Primary prevention may be a way to lower the risk burden of coronary heart disease, but we must establish that preventive programs are cost-effective.
METHODS: Through the use of a stochastic Markov model, which predicts reduction in coronary heart disease events based on risk factor reductions, this study evaluates the results of a previous controlled trial in middle-aged men comparing dietary advice, exercise, and the combination of both applied to an observed cohort of 60-year-old men in the county of Stockholm.
RESULTS: The model predicts lower costs and higher effectiveness for dietary advice compared to the alternatives. Assuming a declining effect of the intervention, dietary advice saves 0.0228 life-years compared to no intervention. If no decline is assumed, the corresponding figure is 0.0997 life-years. From the societal perspective, the added costs are 2,892 Swedish Kronor (SEK) and 14,106 SEK for the two modeling assumptions, resulting in a cost-effectiveness of 127,065 SEK per life-year gained (LYG) and 141,555 SEK/LYG. These figures are below what is generally thought of as cost-effective.
CONCLUSION: Based on the model, dietary advice appears to be the most cost-effective of the studied interventions.

Entities:  

Mesh:

Year:  2003        PMID: 12649048     DOI: 10.1016/s0091-7435(02)00060-9

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  9 in total

1.  AGING OF THE SUBVENTRICULAR ZONE NEURAL STEM CELL NICHE.

Authors:  Joanne C Conover; Brett A Shook
Journal:  Aging Dis       Date:  2011-01-01       Impact factor: 6.745

Review 2.  Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions.

Authors:  J David Spence
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

3.  The value of clopidogrel in addition to standard therapy in reducing atherothrombotic events.

Authors:  William Weintraub; Bengt Jönsson; Michel Bertrand
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 4.  Economic evaluation and transferability of physical activity programmes in primary prevention: a systematic review.

Authors:  Silke B Wolfenstetter; Christina M Wenig
Journal:  Int J Environ Res Public Health       Date:  2010-04-09       Impact factor: 3.390

Review 5.  Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.

Authors:  Sanjib Saha; Ulf-G Gerdtham; Pia Johansson
Journal:  Int J Environ Res Public Health       Date:  2010-08-09       Impact factor: 3.390

6.  The cost of changing physical activity behaviour: evidence from a "physical activity pathway" in the primary care setting.

Authors:  Christian E H Boehler; Karen E Milton; Fiona C Bull; Julia A Fox-Rushby
Journal:  BMC Public Health       Date:  2011-05-23       Impact factor: 3.295

Review 7.  Are brief interventions to increase physical activity cost-effective? A systematic review.

Authors:  Vijay GC; Edward C F Wilson; Marc Suhrcke; Wendy Hardeman; Stephen Sutton
Journal:  Br J Sports Med       Date:  2015-10-05       Impact factor: 13.800

8.  Cost-effectiveness of a telephone-delivered intervention for physical activity and diet.

Authors:  Nicholas Graves; Adrian G Barnett; Kate A Halton; Jacob L Veerman; Elisabeth Winkler; Neville Owen; Marina M Reeves; Alison Marshall; Elizabeth Eakin
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

9.  Are lifestyle interventions in primary care cost-effective?--An analysis based on a Markov model, differences-in-differences approach and the Swedish Björknäs study.

Authors:  Sanjib Saha; Katarina Steen Carlsson; Ulf-G Gerdtham; Margareta K Eriksson; Lars Hagberg; Mats Eliasson; Pia Johansson
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.